CLINICAL IMMUNOLOGY
Combined immunodeficiencies: twenty years experience from a single center in Turkey
Submission date: 2015-08-25
Final revision date: 2015-10-06
Acceptance date: 2015-10-07
Publication date: 2016-01-20
Cent Eur J Immunol 2016;41(1):107-115
KEYWORDS
ABSTRACT
Combined immunodeficiencies (CIDs) include a group of inherited monogenic disorders. CIDs are characterized by defective cellular and humoral immunities that lead to severe infections. CIDs can be classified according to immunologic phenotypes as T–B–NK– CID, T–B–NK+ CID, T–B+NK– CID and T–B+NK+ CID. In a 20-year period, from 1994 to 2014, a total of 40 CID patients were diagnosed at the Pediatric Immunology of Erciyes University Medical Faculty in Kayseri, Turkey. The gender ratio (F/M) was 3/5. The median age at the onset of symptoms was 2 months (range, 15 days – 15 years). Of the 14 T–B–NK– CIDs, 6, 2 (siblings), 1, 1 and 4 had a mutation in the ADA, PNP, Artemis, RAG1 genes and unknown genetic diagnosis respectively. Of the 15 T–B–NK+ CIDs, 3, 2 (siblings) and 10 had a mutation in the RAG1, XLF/Cernunnos genes and unknown genetic diagnosis respectively. Of the 9 T–B+NK– CIDs, 2 siblings, 1, 1 and 5 had a mutation in the ZAP70, IL2RG, DOCK8 genes and unknown genetic diagnosis respectively. Of the 2 T–B+NK+ CIDs, 2 had a mutation in the MAGT1 and ZAP70 genes respectively. Of the 40 CIDs, 26 (65%) were died and 14 (35%) are alive. Eight patients received HSCT (hematopoietic stem cell transplantation) with 62.5% survival rate. As a result, patients presented with severe infections in the first months of life have to be examined for CIDs. Shortening time of diagnosis would increase chance of HSCT as life-saving treatment in the CID patients.
REFERENCES (28)
1.
Azarsiz E, Gulez N, Edeer Karaca N, et al. (2011): Aksu G, Kutukculer N. Consanguinity rate and delay in diagnosis in Turkish patients with combined immunodeficiencies: a single-center study. J Clin Immunol 31: 106-111.
2.
Al-Herz W, Bousfiha A, Casanova JL, et al. (2014): Primary immunodeficiency diseases: an update on the classification from the international union of immunological societies expert committee for primary immunodeficiency. Front Immunol 5: 162.
3.
Aloj G, Giardino G, Valentino L, et al. (2012): Severe combined immunodeficiences: new and old scenarios. Int Rev Immunol 31: 43-65.
4.
Cirillo E, Giardino G, Gallo V, et al. (2015): Severe combined immunodeficiency-an update. Ann N Y Acad Sci 1356: 60-106.
5.
Pasic S, Vujic D, Veljković D, et al. (2014): Severe combined immunodeficiency in Serbia and Montenegro between years 1986 and 2010: a single-center experience. J Clin Immunol 34: 304-308.
6.
Lipstein EA, Vorono S, Browning MF, et al. (2010): Systematic evidence review of newborn screening and treatment of severe combined immunodeficiency. Pediatrics 125: e1226-e1235.
7.
Stephan JL, Vlekova V, Le Deist F, et al. (1993): Severe combined immunodeficiency: a retrospective single-center study of clinical presentation and outcome in 117 patients. J Pediatr 123: 564-572.
8.
Mazzucchelli JT, Bonfim C, Castro GG, et al. (2014): Severe combined immunodeficiency in Brazil: management, prognosis, and BCG-associated complications. J Investig Allergol Clin Immunol 24: 184-191.
9.
Patiroglu T, Akar HH, Gilmour K, et al. (2014): Atypical severe combined immunodeficiency caused by a novel homozygous mutation in Rag1 gene in a girl who presented with pyoderma gangrenosum: a case report and literature review. J Clin Immunol 34: 792-795.
10.
Notarangelo LD (2014): Combined immunodeficiencies with nonfunctional T lymphocytes. Adv Immunol 121: 121-190.
11.
Conley ME, Notarangelo LD, Etzioni A (1999): Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies). Clin Immunol 93: 190-197.
12.
Ikinciog˘ullari A, Kendirli T, Dog˘u F, et al. (2004): Peripheral blood lymphocyte subsets in healthy Turkish children. Turk J Pediatr 46: 125-130.
13.
Aksu G, Genel F, Koturog˘lu G, et al. (2006): Serum immunoglobulin (IgG, IgM, IgA) and IgG subclass concentrations in healthy children: a study using nephelometric technique. Turk J Pediatr 48: 19-24.
14.
la Marca G, Canessa C, Giocaliere E, et al (2014): Diagnosis of immunodeficiency caused by a purine nucleoside phosphorylase defect by using tandem mass spectrometry on dried blood spots. J Allergy Clin Immunol 134: 155-159.
15.
Bousfiha AA, Jeddane L, Ailal F, et al. (2013): A phenotypic approach for IUIS PID classification and diagnosis: guidelines for clinicians at the bedside. J Clin Immunol 33: 1078-1087.
17.
Yao CM, Han XH, Zhang YD, et al. (2013): Clinical characteristics and genetic profiles of 44 patients with severe combined immunodeficiency (SCID): report from Shanghai, China (2004-2011). J Clin Immunol 33: 526-539.
18.
Felgentreff K, Perez-Becker R, Speckmann CG, et al. (2011): Clinical and immunological manifestations of patients with atypical severe combined immunodeficiency. Clin Immunol 141: 73-82.
19.
Michos A, Tzanoudaki M, Villa A, et al. (2011): Severe combined immunodeficiency in Greek children over a 20-year period: rarity of c-chain deficiency (X-linked) type. J Clin Immunol 31: 778-783.
20.
Reda SM, Afifi HM, Amine MM, et al. (2009). Primary immunodeficiency diseases in Egyptian children: a single-center study. J Clin Immunol 29: 343-351.
21.
Gossage DL, Buckley RH (1990): Prevalence of lymphocytopenia in severe combined immunodeficiency. N Engl J Med 323: 1422-1423.
22.
Buckley RH, Schiff RI, Schiff SE, et al. (1997): Human severe combined immunodeficiency: genetic, phenotypic, and functional diversity in one hundred eight infants. J Pediatr 130: 378-387.
23.
Patiroglu T, Akar HH, van der Burg M, et al. (2014): X-linked severe combined immunodeficiency due to a novel mutation complicated with hemophagocytic lymphohistiocytosis and presented with invagination: A case report. Eur J Microbiol Immunol (Bp) 4: 174-176.
24.
Akar HH, Patiroglu T, Akyildiz BN, et al. (2015): Silent brain infarcts in two patients with zeta chain-associated protein 70kDa (ZAP70) deficiency. Clin Immunol 158:88-91.
25.
Patiroglu T, Haluk Akar H, Gilmour K, et al. (2015): A case of XMEN syndrome presented with severe auto-immune disorders mimicking autoimmune lymphoproliferative disease. Clin Immunol 159: 58-62.
26.
Patiroglu T, Akar HH, Unal E, et al. (2014): Malignancies in primary immunodeficiencies: A single center experience. Pediatr Allergy Immunol Pulmonol; DOI: 10.1089/ped.2014.0453.
27.
Patiroglu T, Akar HH, van der Burg M, et al. (2015): A case of XLF deficiency presented with diffuse large B cell lymphoma in the brain. Clin Immunol 161: 394-395.
28.
Buckley RH (2011): Transplantation of hematopoietic stem cells in human severe combined immunodeficiency: longterm outcomes. Immunol Res 49: 25-43.
| eISSN: | 1644-4124 |
| ISSN: | 1426-3912 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
